AI Article Synopsis
- The clinical path for treating acute myeloid leukemia (AML) at the hospital has been in place since 2003, involving laboratory technologists who explain test results to patients and their families using a view-sharing microscope.
- Between July 2003 and October 2014, 56 patients were involved, with a median age of 62 and average explanation time of 40 minutes, leading to improved understanding of their disease and its treatment as indicated by feedback surveys.
- The hospital has enhanced the explanation process by creating a better environment and improving privacy, while hematological laboratory technologists actively participate in medical conferences to collaborate with other healthcare providers to enhance patient care and satisfaction.
Article Abstract
The clinical path for the treatment of acute myeloid leukemia (AML) patients has been in practice in our hospital since 2003. In the clinical path, laboratory technologists take on the role of explaining the microscopic findings in bone marrow and peripheral blood samples to patients (with or without their families) using the view-sharing microscope in our laboratory. From July 2003 to October 2014, 56 patients were enrolled in the AML clinical path and given an explanation of their bone marrow and peripheral blood samples. The patients' median age was 62, and the median time spent for explanation was 40 minutes. We conducted a questionnaire feedback survey involving those who enrolled, and the results showed significant improvement in the recognition of the disease pathophysiology, treatment efficacy, and the importance of precautions against infectious diseases. Based on the feedback, we have made marked efforts to provide patients with an improved environment during the explanatory session. This includes installing a special display for the patients, drawing a schematic illustration that shows how the blood cells differentiate, and putting them into operation in a hematology ward to promote patient privacy and precautions against infectious diseases. Hematological laboratory technologists have played an important role in patient care in our hospital. To perform their role as effectively as possible, hematological laboratory technologists participate in the conferences of the Department of Hematology and Oncology regularly, in which medical staff members can discuss the conditions and clinical courses of patients. We aim to contribute to patient satisfaction by sophisticating specialized knowledge as hematological laboratory technologists and cooperate with other medical staff members.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Technical Competency Assessment of Peripheral Blood Smears: Tools and Trends Learned From 2 College of American Pathologists Q-Probes Studies.
Arch Pathol Lab Med
December 2024
From the Biostatistics Department College of American Pathologists, Northfield, Illinois (Coulter, Souers).
Context.—: Morphologic evaluation of peripheral blood smears provides valuable information to diagnose and manage a variety of hematologic disorders.
Objective.
Effect of Hemolysis on Routine Blood Gas and Whole Blood Analytes.
J Appl Lab Med
December 2024
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Background: Hemolysis is a major pre-analytical concern for many laboratory analytes; however, instruments utilized for whole blood chemistries and blood gas measurements lack the ability to detect and measure the degree of hemolysis. This study evaluated the effect of hemolysis on 13 routine whole blood and blood gas analytes and compared visual assessments of hemolysis to measured hemolysis (H-index).
Methods: Remnant whole blood samples (n = 85) were split into 2 portions and aspirated through a syringe one or more times.
Barriers and facilitators of the electronic medical record adoption among healthcare providers in Addis Ababa, Ethiopia.
Digit Health
December 2024
JSI Research and Training Institute Inc., Addis Ababa, Ethiopia.
Introduction: An electronic medical record (EMR) can enhance the quality of care and patient outcomes. Ethiopia started the implementation of EMR in 2013. However, its adoption among healthcare providers has been low.
View Article and Find Full Text PDFBacteriology testing and antimicrobial resistance detection capacity of national tiered laboratory networks in sub-Saharan Africa: an analysis from 14 countries.
Lancet Microbe
December 2024
One Health Trust, Washington, DC, USA.
Background: Accurate detection of antimicrobial resistance (AMR) depends on adequate laboratory capacity. We aimed to document key weaknesses hindering AMR detection at various tiers of laboratory networks in 14 countries in sub-Saharan Africa, and analyse their significance in AMR surveillance and policies.
Methods: In this analysis, we obtained retrospective data on AMR and antimicrobial consumption from 14 countries participating in the Mapping Antimicrobial Resistance and Antimicrobial Use Partnership between May 1, 2019, and June 30, 2020.
Shedding new light on : how the use of ultraviolet fluorescence microscopy can improve diagnosis of cyclosporiasis.
J Clin Microbiol
December 2024
Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
Unlabelled: Cyclosporiasis has historically been underdiagnosed due to a lack of clinical recognition and challenges in laboratory detection. Microscopic detection of requires either the modified Kinyoun's acid-fast or safranin stains, which are not part of the standard ova-and-parasite examination. Alternatively, the use of fluorescence microscopy for the detection of due to the organism's autofluorescent properties has been an available tool in the field of clinical parasitology.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!